Quest Diagnostics, Inc. (DGX) Misses Q1 EPS by 14c; Sees Slightly Weaker FY13 Revenue
Quest Diagnostics, Inc. (NYSE: DGX) reported Q1 EPS of $0.89, $0.14 worse than the analyst estimate of $1.03. Revenue for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
